Raymond James & Associates’s Nuveen Short-Term REIT ETF NURE Stock Holding History
Bought
Maintained
Sold
Other funds holding NURE
HW
TRCT
AWM
MI
ACP
Raymond James & Associates's NURE Position: Q1 2023 in Review
Raymond James & Associates sold out of Nuveen Short-Term REIT ETF (NURE) in Q1 2023, closing a stake of 12,093 shares — an estimated $344K sold.
Raymond James & Associates first reported a position in NURE in Q2 2021 and held it in 7 quarters. The position peaked at $344K in Q4 2022. 33 funds tracked by Wall St. Rank hold NURE as of Q1 2023.
- Raymond James & Associates reported no remaining Nuveen Short-Term REIT ETF position as of Q1 2023 after selling out during the quarter.
- Raymond James & Associates sold 12,093 Nuveen Short-Term REIT ETF shares in Q1 2023, an estimated $344K.
- Raymond James & Associates first reported a position in Nuveen Short-Term REIT ETF in Q2 2021 and held it in 7 quarters.
- Raymond James & Associates's Nuveen Short-Term REIT ETF position peaked at $344K in Q4 2022.
- 33 funds tracked by Wall St. Rank held Nuveen Short-Term REIT ETF as of Q1 2023.
Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.